Dysport (abobotulinumtoxinA)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) July 2016 ADVERSE REACTIONS The following serious adverse reactions are discussed below and elsewhere in labeling: (additions) ...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts